Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30024753HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS30024754HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS30024755HIVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20031395HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20048477HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20047262HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20047848HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TVIS20042271HPVENSG00000171385.11protein_codingKCND3NoNo3752Q9UK17
TCGA Plot Options
Drug Information
GeneKCND3
DrugBank IDDB06637
Drug NameDalfampridine
Target IDBE0003604
UniProt IDQ9UK17
Regulation Typeantagonist
PubMed IDs16472864
CitationsJudge SI, Bever CT Jr: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006 Jul;111(1):224-59. Epub 2006 Feb 9.
GroupsApproved
Direct ClassificationAminopyridines and derivatives
SMILESNC1=CC=NC=C1
Pathways
PharmGKBPA166123389
ChEMBLCHEMBL284348